Espinoza Octavio bought LGND
December 16, 2025 · Form 4 insider transaction
Espinoza Octavio bought 652 shares of Ligand Pharmaceuticals Incorporated at $92.65 per share, a transaction worth $60.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
652
Price
$92.65
Total value
$60.4K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after28,386
OwnershipDirect
10b5-1 planNo
AmendedNo